IRCT20220211053992N25招募中Unknown
In vivo fasted-state bioequivalence study of omeprazole 20 mg Capsules manufactured by Fatak Chemie Pars Co. compared to innovator product
Fatak Chemie Pars0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
- •Age (18-59 years old)
排除标准
- •History of cardiovascular, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
Unknown
In vivo Bioequivalence study of Evererolimus tabletsIRCT20220211053992N31Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Emtricitabine/Tenofovir tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N38Tabriz University of Medical Sciences24
招募中
Unknown
In vivo Bioequivalence study of Primidone suspensioIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N17Tabriz University of Medical Sciences24
招募中
Unknown
In vivo Bioequivalence study of Metformin tabletIRCT20220211053992N26Tabriz University of Medical Sciences24
招募中
不适用
Investigating the in vivo bioequivalence of Eplerenone 25 mgIRCT20210519051345N20Tabriz University of Medical Sciences24